These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23927715)

  • 1. Passively transferred human NMO-IgG exacerbates demyelination in mouse experimental autoimmune encephalomyelitis.
    Saini H; Rifkin R; Gorelik M; Huang H; Ferguson Z; Jones MV; Levy M
    BMC Neurol; 2013 Aug; 13():104. PubMed ID: 23927715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repetitive intrathecal injection of human NMO-IgG with complement exacerbates disease severity with NMO pathology in experimental allergic encephalomyelitis mice.
    Lee CL; Wang KC; Chen SJ; Chen CM; Tsai CP; Chen SY
    Mult Scler Relat Disord; 2019 May; 30():225-230. PubMed ID: 30825702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.
    Marignier R; Ruiz A; Cavagna S; Nicole A; Watrin C; Touret M; Parrot S; Malleret G; Peyron C; Benetollo C; Auvergnon N; Vukusic S; Giraudon P
    J Neuroinflammation; 2016 May; 13(1):111. PubMed ID: 27193196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low Frequency Ultrasound With Injection of NMO-IgG and Complement Produces Lesions Different From Experimental Autoimmune Encephalomyelitis Mice.
    Xiang W; Xie C; Luo J; Zhang W; Zhao X; Yang H; Cai Y; Ding J; Wang Y; Hao Y; Zhang Y; Guan Y
    Front Immunol; 2021; 12():727750. PubMed ID: 34721390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms.
    Zhang H; Bennett JL; Verkman AS
    Ann Neurol; 2011 Dec; 70(6):943-54. PubMed ID: 22069219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS.
    Zeka B; Hastermann M; Hochmeister S; Kögl N; Kaufmann N; Schanda K; Mader S; Misu T; Rommer P; Fujihara K; Illes Z; Leutmezer F; Sato DK; Nakashima I; Reindl M; Lassmann H; Bradl M
    Acta Neuropathol; 2015 Dec; 130(6):783-98. PubMed ID: 26530185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
    Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W
    Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Brown Norway opticospinal model of demyelination: does it mimic multiple sclerosis or neuromyelitis optica?
    Collongues N; Chanson JB; Blanc F; Steibel J; Lam CD; Shabbir A; Trifilieff E; Honnorat J; Pham-Dinh D; Ghandour MS; de Seze J
    Int J Dev Neurosci; 2012 Oct; 30(6):487-97. PubMed ID: 22634288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental mouse model of optic neuritis with inflammatory demyelination produced by passive transfer of neuromyelitis optica-immunoglobulin G.
    Asavapanumas N; Ratelade J; Papadopoulos MC; Bennett JL; Levin MH; Verkman AS
    J Neuroinflammation; 2014 Jan; 11():16. PubMed ID: 24468108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recent progress in multiple sclerosis research: astrocytopathy in demyelinating diseases].
    Kira J
    Rinsho Shinkeigaku; 2010 Nov; 50(11):788-93. PubMed ID: 21921443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody.
    Kurosawa K; Misu T; Takai Y; Sato DK; Takahashi T; Abe Y; Iwanari H; Ogawa R; Nakashima I; Fujihara K; Hamakubo T; Yasui M; Aoki M
    Acta Neuropathol Commun; 2015 Dec; 3():82. PubMed ID: 26637322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aquaporin-4 autoantibodies cause asymptomatic aquaporin-4 loss and activate astrocytes in mouse.
    Chan KH; Zhang R; Kwan JS; Guo VY; Ho PW; Ho JW; Chu AC
    J Neuroimmunol; 2012 Apr; 245(1-2):32-8. PubMed ID: 22394609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models.
    Wu Y; Zhong L; Geng J
    Mult Scler Relat Disord; 2019 Jan; 27():412-418. PubMed ID: 30530071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromyelitis optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury.
    Asavapanumas N; Verkman AS
    Acta Neuropathol Commun; 2014 Apr; 2():48. PubMed ID: 24758159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marked central nervous system pathology in CD59 knockout rats following passive transfer of Neuromyelitis optica immunoglobulin G.
    Yao X; Verkman AS
    Acta Neuropathol Commun; 2017 Feb; 5(1):15. PubMed ID: 28212662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss.
    Ratelade J; Zhang H; Saadoun S; Bennett JL; Papadopoulos MC; Verkman AS
    Acta Neuropathol; 2012 Jun; 123(6):861-72. PubMed ID: 22526022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
    Roemer SF; Parisi JE; Lennon VA; Benarroch EE; Lassmann H; Bruck W; Mandler RN; Weinshenker BG; Pittock SJ; Wingerchuk DM; Lucchinetti CF
    Brain; 2007 May; 130(Pt 5):1194-205. PubMed ID: 17282996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica.
    Ratelade J; Asavapanumas N; Ritchie AM; Wemlinger S; Bennett JL; Verkman AS
    Acta Neuropathol; 2013 Nov; 126(5):699-709. PubMed ID: 23995423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica.
    Hinson SR; Pittock SJ; Lucchinetti CF; Roemer SF; Fryer JP; Kryzer TJ; Lennon VA
    Neurology; 2007 Dec; 69(24):2221-31. PubMed ID: 17928579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromyelitis Optica Spectrum Disorder Treatment-Current and Future Prospects.
    Waliszewska-Prosół M; Chojdak-Łukasiewicz J; Budrewicz S; Pokryszko-Dragan A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.